UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 94

Sortiert nach

Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction

Nature medicine, 2015-02, Vol.21 (2), p.140-149

2015

Link zum Volltext

Verfügbarkeit prüfen

Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC

Frontiers in immunology, 2020-09, Vol.11, p.564133-564133

2020

Link zum Volltext

Verfügbarkeit prüfen

Dipeptidyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type 2 diabetes

Current topics in medicinal chemistry, 2007-03, Vol.7 (6), p.547

2007

Link zum Volltext

Verfügbarkeit prüfen

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

Cardiovascular diabetology, 2011-01, Vol.10 (1), p.7-7

2011

Link zum Volltext

Verfügbarkeit prüfen

Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes

PloS one, 2012-04, Vol.7 (4), p.e35012-e35012

2012

Link zum Volltext

Verfügbarkeit prüfen

Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart

Circulation (New York, N.Y.), 1999-01, Vol.99 (3), p.384-391

1999

Link zum Volltext

Verfügbarkeit prüfen

Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5

The Journal of pharmacology and experimental therapeutics, 2001-09, Vol.298 (3), p.1108

2001

Link zum Volltext

Verfügbarkeit prüfen

Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction

Nature communications, 2014-12, Vol.5 (1), p.5863-5863, Article 5863

2014

Link zum Volltext

Verfügbarkeit prüfen

Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey Models

Investigative ophthalmology & visual science, 2018-06, Vol.59 (7), p.2687-2698

2018

Link zum Volltext

Verfügbarkeit prüfen

The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport

Cardiovascular research, 2008-03, Vol.77 (4), p.732-739

2008

Link zum Volltext

Verfügbarkeit prüfen

A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro

Molecular endocrinology (Baltimore, Md.), 2006-04, Vol.20 (4), p.809-830

2006

Link zum Volltext

Verfügbarkeit prüfen

Outlook: finding improved medicines: the role of academic-industrial collaboration

Nature reviews. Drug discovery, 2005-11, Vol.4 (11), p.891-897

2005

Link zum Volltext

Verfügbarkeit prüfen

Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD)

Nephrology, dialysis, transplantation, 2012-10, Vol.27 Suppl 3 (suppl 3), p.iii81-iii88

2012

Link zum Volltext

Verfügbarkeit prüfen

Erratum: Corrigendum: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction

Nature medicine, 2016-04, Vol.22 (4), p.446-446

2016

Link zum Volltext

Verfügbarkeit prüfen

Corrigendum: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction

Nature medicine, 2016-04, Vol.22 (4), p.446-446

2016

Link zum Volltext

Verfügbarkeit prüfen

Current drug development challenges in chronic kidney disease (CKD)—identification of individualized determinants of renal progression and premature cardiovascular disease (CVD): CKD: A Research and Public Health Priority

Nephrology, dialysis, transplantation, 2012, Vol.27

2012

Link zum Volltext

Verfügbarkeit prüfen

HepG2/C3A 3D spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation

Toxicology research (Cambridge), 2013-01, Vol.2 (3), p.163-172

2013

Link zum Volltext

Verfügbarkeit prüfen

Finding improved medicines: the role of academic-industrial collaboration

Nature reviews. Drug discovery, 2005-11, Vol.4 (11), p.891-897

2005

Link zum Volltext

Verfügbarkeit prüfen

Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome

Diabetes & vascular disease research, 2013-07, Vol.10 (4), p.368-374

2013

Link zum Volltext

Verfügbarkeit prüfen

The Discovery of a New Organic Nitrate: An Overview

Journal of cardiovascular pharmacology, 1995, Vol.26 Suppl 4, p.S1-5

1995

Link zum Volltext

Verfügbarkeit prüfen

Receptors for substance P.I. The pharmacological preparations

European journal of pharmacology, 1984, Vol.97 (3), p.161-170

1984

Link zum Volltext

Verfügbarkeit prüfen

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor [alpha]/[gamma] agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

Cardiovascular diabetology, 2011-01, Vol.10, p.7

2011

Link zum Volltext

Verfügbarkeit prüfen

Receptors for substance P. III. Classification by competitive antagonists

European journal of pharmacology, 1984-01, Vol.97 (3), p.179-189

1984

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 94

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(73)
Mit Volltextzugriff
(68)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(48)
Life Sciences & Biomedicine
(45)
Animals
(34)
Pharmacology & Pharmacy
(26)
Male
(25)
Humans
(22)
In Vitro Techniques
(22)
Biological And Medical Sciences
(18)
Medicine
(17)
Cardiovascular System & Cardiology
(14)
Female
(13)
Guinea Pigs
(13)
Cardiac & Cardiovascular Systems
(12)
Muscle, Smooth - Drug Effects
(12)
Rabbits
(12)
Dogs
(11)
Rats
(11)
Muscle Contraction - Drug Effects
(10)
Substance P - Pharmacology
(10)
Fundamental And Applied Biological Sciences. Psychology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction

Expression of TAM-R in Human Immune Cells and Unique Regulatory Function of MerTK in IL-10 Production by Tolerogenic DC

Dipeptidyl peptidase IV inhibitors: the next generation of new promising therapies for the management of type 2 diabetes

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

Comparative transcriptional network modeling of three PPAR-α/γ co-agonists reveals distinct metabolic gene signatures in primary human hepatocytes

Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart

Effects of anorexinogen agents on cloned voltage-gated K(+) channel hKv1.5

Telomerase expression confers cardioprotection in the adult mouse heart after acute myocardial infarction

Anti-CD160, Alone or in Combination With Bevacizumab, Is a Potent Inhibitor of Ocular Neovascularization in Rabbit and Monkey Models

Combining robust urine biomarkers to assess chronic kidney disease progressionResearch in context

The effect of cholesteryl ester transfer protein overexpression and inhibition on reverse cholesterol transport

Combining robust urine biomarkers to assess chronic kidney disease progression

A Novel Partial Agonist of Peroxisome Proliferator-Activated Receptor-γ (PPARγ) Recruits PPARγ-Coactivator-1α, Prevents Triglyceride Accumulation, and Potentiates Insulin Signaling in Vitro

Outlook: finding improved medicines: the role of academic-industrial collaboration

Current drug development challenges in chronic kidney disease (CKD)--identification of individualized determinants of renal progression and premature cardiovascular disease (CVD)

Erratum: Corrigendum: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction

Corrigendum: Myeloid-derived growth factor (C19orf10) mediates cardiac repair following myocardial infarction

Current drug development challenges in chronic kidney disease (CKD)—identification of individualized determinants of renal progression and premature cardiovascular disease (CVD): CKD: A Research and Public Health Priority

HepG2/C3A 3D spheroids exhibit stable physiological functionality for at least 24 days after recovering from trypsinisation

Finding improved medicines: the role of academic-industrial collaboration

Endothelial dysfunction in patients with type 2 diabetes post acute coronary syndrome

The Discovery of a New Organic Nitrate: An Overview

Receptors for substance P.I. The pharmacological preparations

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor [alpha]/[gamma] agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

Receptors for substance P. III. Classification by competitive antagonists

Suchergebnisse filtern